Fidelity NorthStar® Balanced Fund

Investment Strategy

Fidelity NorthStar® Balanced Fund is a balanced solution that offers investors the potential for long-term capital growth. The Fund employs a flexible approach that draws on the portfolio managers' best ideas across an expansive range of equity securities and fixed-income asset classes from around the world.

Performance

Performance for this series is not available at this time.

Performance

Annual compound performance – as at 31-Aug-2017

PERIOD Fund
1 month 0.37% 3
3 month -5.92% 4
6 month -2.89% 4
1 year -0.85% 4
2 year 0.89% 4
3 year 6.95% 1
5 year
7 year
10 year
YTD -2.07% 4
Since Inception 7.06%

Calendar year performance – as at 31-Aug-2017

Calendar year performance – as at 31-Aug-2017

Growth of $10,000 since inception³ – as at 31-Aug-2017

Growth of $10,000 since inception³ – as at 31-Aug-2017
Fund risk measures – as at 31-Aug-2017
  Fund
Annual Standard Deviation 9.13
Beta 0.97
0.84

Risk measures are based on 3-year net returns (series B). (All returns are calculated in Canadian currency.) 

Volatility meter

Low to Medium

A fund’s volatility is determined using a statistical measure called “standard deviation". Standard deviation measures the amount of variability of returns that has historically occurred relative to the average return. The higher the standard deviation of a fund, the greater the range of returns it has experienced in the past. Other types of risk, both measurable and non-measurable, exist. In addition, just as historical performance may not be indicative of future returns, a fund’s historical volatility may not be indicative of its future volatility.

PM - Joel Tillinghast- Lessons learned over a thirty year - EN

Fund facts

NAVPU – Series B

$9.55 – as at 22-Sep-2017

NAVPU – Series B

$11.79 – as at 22-Sep-2017

Series inception date

28-May-2014

28-May-2014

Fund benchmark

None

Fund aggregate assets (all series)

$3.857 billion
as at 31-Aug-2017

Management expense ratio - Series B

2.25% – as at 30-Sep-2016

 
Quarterly Top Ten Holdings
Anthem  
Seria Co.  
Gilead Sciences  
Ottogi  
Teva Pharmaceutical  
Bed Bath & Beyond  
Hon Hai Precision  
Hyundai Mobis  
Deckers Outdoor  
Amgen  
Total number of holdings 1,755
Top 10 holdings aggregate 9.4%
Allocation to funds

Asset Mix
as at 31-Jul-2017

  Current monthLast monthTwo months ago
Foreign Equities 32.0%30.2%29.6%
Foreign Bonds 29.7%29.6%29.7%
High Yield Bonds 16.7%16.8%16.4%
Other Investments 0.7%0.7%0.7%
Cash & Other 20.9%22.8%23.7%

Top historical sector mix (%)
as at 31-Jul-2017

Consumer Discretionary 7.8%8.2%8.2%
Health Care 7.5%7.3%6.9%
Consumer Staples 4.7%3.9%4.7%
Information Technology 3.9%3.4%2.9%
Industrials 3.3%3.0%2.9%
Financials 2.0%1.8%1.7%
Materials 1.4%1.2%1.0%
Energy 1.0%0.9%1.0%

Country mix (%)
as at 31-Jul-2017

United States 69.7%71.4%71.7%
Japan 6.5%6.3%6.3%
South Korea 3.4%3.2%3.5%
Canada 2.8%2.2%2.7%
United Kingdom 2.3%2.2%2.3%
Netherlands 1.9%1.3%1.1%
Mexico 1.5%1.5%1.5%
Israel 1.4%1.4%1.0%
Taiwan 1.4%1.4%1.3%
Hong Kong 1.3%1.3%1.2%
702766.69.0